Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.23.1
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2022
Mar. 16, 2023
Jun. 30, 2022
Document Information [Line Items]      
Document Type 10-K/A    
Amendment Flag true    
Amendment Description This Amendment No. 1 on Form 10-K/A (“Amendment No. 1”) is being filed to amend our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (“the “Original Filing”), filed with the U.S. Securities and Exchange Commission on March 16, 2023 (the “Original Filing Date”). The sole purpose of this Amendment No. 1 is to correct a typographical error in the previously filed Consent of Independent Registered Public Accounting Firm (filed as Exhibit 23.1), which inadvertently referenced the incorrect date with respect to the Report of Independent Registered Public Accounting Firm. Except as described above, no changes have been made to the Original Filing and this Amendment No. 1 does not modify, amend or update in any way any of the financial or other information contained in the Original Filing. This Amendment No. 1 does not reflect events that may have occurred subsequent to the Original Filing Date. Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended, this Amendment No. 1 also contains a new certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, which is attached hereto. Because no financial statements have been included in this Amendment No. 1 and this Amendment No. 1 does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted.    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Document Transition Report false    
Document Annual Report true    
Trading Symbol ACHV    
Entity Incorporation, State or Country Code DE    
Entity Registrant Name Achieve Life Sciences, Inc.    
Entity Central Index Key 0000949858    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Shell Company false    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity File Number 033-80623    
Entity Tax Identification Number 95-4343413    
Entity Address, Address Line One 22722 29th Drive SE    
Entity Address, Address Line Two Suite 100    
Entity Address, City or Town Bothell    
Entity Address, State or Province WA    
Entity Address, Postal Zip Code 98021    
City Area Code 604    
Local Phone Number 210-2217    
Entity Common Stock, Shares Outstanding   17,930,362  
Entity Public Float     $ 47,146,099
Title of 12(b) Security Common Stock, par value $0.001 per share    
Security Exchange Name NASDAQ    
ICFR Auditor Attestation Flag false    
Auditor Firm ID 271    
Auditor Name PricewaterhouseCooopers LLP    
Auditor Location Vancouver, BC, Canada    
Documents Incorporated by Reference

Portions of the Registrant’s Definitive Proxy Statement for its 2023 Annual Meeting of Stockholders (“Proxy Statement”), to be filed within 120 days of the Registrant’s fiscal year ended December 31, 2022, is incorporated by reference into Part III of this Annual Report on Form 10-K.

   
Principal Address      
Document Information [Line Items]      
Entity Address, Address Line One 1040 West Georgia Street    
Entity Address, Address Line Two Suite 1030    
Entity Address, City or Town Vancouver    
Entity Address, State or Province BC    
Entity Address, Postal Zip Code V6E 4H1